Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 45, 2015
Previous Article Next Article

Graphene quantum dots for the inhibition of β amyloid aggregation

Author affiliations

Abstract

The aggregation of Aβ peptides is a crucial factor leading to Alzheimer's disease (AD). Inhibiting the Aβ peptide aggregation has become one of the most essential strategies to treat AD. In this work, efficient and low-cytotoxicity inhibitors, graphene quantum dots (GQDs) are reported for their application in inhibiting the aggregation of Aβ peptides. Compared to other carbon materials, the low cytotoxicity and great biocompatibility of GQDs give an advantage to the clinical research for AD. In addition, the GQDs may cross the blood–brain barrier (BBB) because of the small size. It is believed that GQDs may be therapeutic agents against AD. This work provides a novel insight into the development of Alzheimer's drugs.

Graphical abstract: Graphene quantum dots for the inhibition of β amyloid aggregation

Back to tab navigation

Supplementary files

Article information


Submitted
12 Sep 2015
Accepted
07 Oct 2015
First published
09 Oct 2015

Nanoscale, 2015,7, 19060-19065
Article type
Paper
Author version available

Graphene quantum dots for the inhibition of β amyloid aggregation

Y. Liu, L. Xu, W. Dai, H. Dong, Y. Wen and X. Zhang, Nanoscale, 2015, 7, 19060
DOI: 10.1039/C5NR06282A

Social activity

Search articles by author

Spotlight

Advertisements